SELLAS Life Sciences Group Inc (NASDAQ: SLS) is -7.55% lower on its value in year-to-date trading and has touched a low of $0.50 and a high of $1.72 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SLS stock was last observed hovering at around $1.01 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.98, the stock is -1.19% and -12.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.08 million and changing -2.97% at the moment leaves the stock -20.63% off its SMA200. SLS registered -6.67% loss for a year compared to 6-month gain of -17.65%. The firm has a 50-day simple moving average (SMA 50) of $1.1254 and a 200-day simple moving average (SMA200) of $1.23485.
The stock witnessed a -18.33% loss in the last 1 month and extending the period to 3 months gives it a -22.22%, and is 9.13% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.97% over the week and 11.04% over the month.
SELLAS Life Sciences Group Inc (SLS) has around 16 employees, a market worth around $66.92M and $0.00M in sales. Distance from 52-week low is 96.55% and -43.02% from its 52-week high. The company has generated returns on investments over the last 12 months (-203.12%).
The EPS is expected to grow by 59.95% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
SELLAS Life Sciences Group Inc (SLS) Top Institutional Holders
35.0 institutions hold shares in SELLAS Life Sciences Group Inc (SLS), with institutional investors hold 7.38% of the company’s shares. The shares outstanding are 70.38M, and float is at 69.73M with Short Float at 10.69%. Institutions hold 7.36% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 1.79 million shares valued at $2.13 million. The investor’s holdings represent 3.9862% of the SLS Shares outstanding. As of 2024-06-30, the second largest holder is SUSQUEHANNA INTERNATIONAL GROUP, LLP with 1.64 million shares valued at $1.95 million to account for 3.6594 of the shares outstanding. The other top investors are ALYESKA INVESTMENT GROUP, L.P. which holds 1.48 million shares representing 3.3005% and valued at over $1.76 million, while GEODE CAPITAL MANAGEMENT, LLC holds 1.1537 of the shares totaling 0.52 million with a market value of $0.62 million.
SELLAS Life Sciences Group Inc (SLS) Insider Activity
#####
